308 related articles for article (PubMed ID: 37812432)
21. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
[TBL] [Abstract][Full Text] [Related]
22. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
Attems J; Jellinger KA
Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
[TBL] [Abstract][Full Text] [Related]
23. Progression of neurofibrillary changes and PHF-tau in end-stage Alzheimer's disease is different from plaque and cortical microglial pathology.
Thal DR; Arendt T; Waldmann G; Holzer M; Zedlick D; Rüb U; Schober R
Neurobiol Aging; 1998; 19(6):517-25. PubMed ID: 10192210
[TBL] [Abstract][Full Text] [Related]
24. Neuropathology of cognitively normal elderly.
Knopman DS; Parisi JE; Salviati A; Floriach-Robert M; Boeve BF; Ivnik RJ; Smith GE; Dickson DW; Johnson KA; Petersen LE; McDonald WC; Braak H; Petersen RC
J Neuropathol Exp Neurol; 2003 Nov; 62(11):1087-95. PubMed ID: 14656067
[TBL] [Abstract][Full Text] [Related]
25. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
[TBL] [Abstract][Full Text] [Related]
26. Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease.
Gómez-Tortosa E; Gonzalo I; Fanjul S; Sainz MJ; Cantarero S; Cemillán C; Yébenes JG; del Ser T
Arch Neurol; 2003 Sep; 60(9):1218-22. PubMed ID: 12975286
[TBL] [Abstract][Full Text] [Related]
27. MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study.
Whitwell JL; Josephs KA; Murray ME; Kantarci K; Przybelski SA; Weigand SD; Vemuri P; Senjem ML; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Dickson DW; Jack CR
Neurology; 2008 Sep; 71(10):743-9. PubMed ID: 18765650
[TBL] [Abstract][Full Text] [Related]
28. Brains of rhesus monkeys display Aβ deposits and glial pathology while lacking Aβ dimers and other Alzheimer's pathologies.
Zhang J; Chen B; Lu J; Wu Y; Wang S; Yao Z; Zhu L; Qiao Y; Sun Q; Qin W; Zhao Q; Jia J; Wei C
Aging Cell; 2019 Aug; 18(4):e12978. PubMed ID: 31165579
[TBL] [Abstract][Full Text] [Related]
29. Neurofibrillary Tangle Stage and the Rate of Progression of Alzheimer Symptoms: Modeling Using an Autopsy Cohort and Application to Clinical Trial Design.
Qian J; Hyman BT; Betensky RA
JAMA Neurol; 2017 May; 74(5):540-548. PubMed ID: 28288263
[TBL] [Abstract][Full Text] [Related]
30. [Expression of proteins related neurodegeneration in autopsy brains of the aged].
Zhu M; Meng X; Wang L; Hu Y; Zhang H; Han Z
Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):651-6. PubMed ID: 25567589
[TBL] [Abstract][Full Text] [Related]
31. [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.
Marquié M; Siao Tick Chong M; Antón-Fernández A; Verwer EE; Sáez-Calveras N; Meltzer AC; Ramanan P; Amaral AC; Gonzalez J; Normandin MD; Frosch MP; Gómez-Isla T
Acta Neuropathol; 2017 Oct; 134(4):619-628. PubMed ID: 28612291
[TBL] [Abstract][Full Text] [Related]
32. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain.
Ingelsson M; Fukumoto H; Newell KL; Growdon JH; Hedley-Whyte ET; Frosch MP; Albert MS; Hyman BT; Irizarry MC
Neurology; 2004 Mar; 62(6):925-31. PubMed ID: 15037694
[TBL] [Abstract][Full Text] [Related]
33. Human astrocytes and microglia show augmented ingestion of synapses in Alzheimer's disease via MFG-E8.
Tzioras M; Daniels MJD; Davies C; Baxter P; King D; McKay S; Varga B; Popovic K; Hernandez M; Stevenson AJ; Barrington J; Drinkwater E; Borella J; Holloway RK; Tulloch J; Moss J; Latta C; Kandasamy J; Sokol D; Smith C; Miron VE; Káradóttir RT; Hardingham GE; Henstridge CM; Brennan PM; McColl BW; Spires-Jones TL
Cell Rep Med; 2023 Sep; 4(9):101175. PubMed ID: 37652017
[TBL] [Abstract][Full Text] [Related]
34. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
Soleimani-Meigooni DN; Iaccarino L; La Joie R; Baker S; Bourakova V; Boxer AL; Edwards L; Eser R; Gorno-Tempini ML; Jagust WJ; Janabi M; Kramer JH; Lesman-Segev OH; Mellinger T; Miller BL; Pham J; Rosen HJ; Spina S; Seeley WW; Strom A; Grinberg LT; Rabinovici GD
Brain; 2020 Dec; 143(11):3477-3494. PubMed ID: 33141172
[TBL] [Abstract][Full Text] [Related]
35. Immune reactive cells in senile plaques and cognitive decline in Alzheimer's disease.
Vehmas AK; Kawas CH; Stewart WF; Troncoso JC
Neurobiol Aging; 2003; 24(2):321-31. PubMed ID: 12498966
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease.
Kouri N; Frankenhauser I; Peng Z; Labuzan SA; Boon BDC; Moloney CM; Pottier C; Wickland DP; Caetano-Anolles K; Corriveau-Lecavalier N; Tranovich JF; Wood AC; Hinkle KM; Lincoln SJ; Spychalla AJ; Senjem ML; Przybelski SA; Engelberg-Cook E; Schwarz CG; Kwan RS; Lesser ER; Crook JE; Carter RE; Ross OA; Lachner C; Ertekin-Taner N; Ferman TJ; Fields JA; Machulda MM; Ramanan VK; Nguyen AT; Reichard RR; Jones DT; Graff-Radford J; Boeve BF; Knopman DS; Petersen RC; Jack CR; Kantarci K; Day GS; Duara R; Graff-Radford NR; Dickson DW; Lowe VJ; Vemuri P; Murray ME
JAMA Neurol; 2024 Jun; 81(6):619-629. PubMed ID: 38619853
[TBL] [Abstract][Full Text] [Related]
37. Distinct amyloid-β and tau-associated microglia profiles in Alzheimer's disease.
Gerrits E; Brouwer N; Kooistra SM; Woodbury ME; Vermeiren Y; Lambourne M; Mulder J; Kummer M; Möller T; Biber K; Dunnen WFAD; De Deyn PP; Eggen BJL; Boddeke EWGM
Acta Neuropathol; 2021 May; 141(5):681-696. PubMed ID: 33609158
[TBL] [Abstract][Full Text] [Related]
38. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
[TBL] [Abstract][Full Text] [Related]
39. Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer's disease, progressive supranuclear palsy, and dementia with Lewy bodies.
Montalbano M; Majmundar L; Sengupta U; Fung L; Kayed R
Brain Pathol; 2023 Jan; 33(1):e13112. PubMed ID: 36054524
[TBL] [Abstract][Full Text] [Related]
40. Neurodegeneration, synaptic dysfunction, and gliosis are phenotypic of Alzheimer dementia.
Merluzzi AP; Carlsson CM; Johnson SC; Schindler SE; Asthana S; Blennow K; Zetterberg H; Bendlin BB
Neurology; 2018 Jul; 91(5):e436-e443. PubMed ID: 29959263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
